Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALEMTUZUMAB vs ALENDRONATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALEMTUZUMAB vs ALENDRONATE: Safety Overview

Metric ALEMTUZUMAB ALENDRONATE
Total FAERS Reports 14,161 27,883
Deaths Reported 1,417 4,541
Death Rate 10.0% 16.3%
Hospitalizations 4,455 11,015
Average Patient Age 38.9 yrs 54.1 yrs
% Female Patients 63.2% 94.3%
FDA Approval Date N/A Apr 22, 2009
Manufacturer Genzyme Corporation EXELAN PHARMACEUTICALS INC.
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued